Vendor, Pennington, NJ
Zydus Pharmaceuticals (Usa) Inc.
UEI QMFQCPLJ9F36, CAGE 6YA44
2 awards and $0 obligated between January 19, 2024 and September 4, 2026, 100% under full and open competition, against 500.0 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Dipeptidyl-Peptidase 4 (DPP-4) Inhibitors Sitagliptin
Department of Veterans Affairs, Nac Pharmaceuticals
Award noticeNAICS 32541236E79723R0037Awarded to Zydus Pharmaceuticals (Usa) Inc. for $113,797,620
Posted Mar 18, 2024
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36E79724D0021March 18, 2024, Full and Open Competition, 1 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | New Award for DPP-4 Sitagliptin with Zydus Pharmaceuticals (Usa)inc. Period of Performance Is 5/18/2024 - 5/17/2025 with Four ONE-YEAR OptioNAICS 325412, PSC 6505 | $0 |
| 36F79721D0223January 19, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | 42-2B: Product AdditionNAICS 325412, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 68 across 2 awards